Cost-utility analysis of nanoparticle albumin-bound paclitaxel versus paclitaxel in monotherapy in pretreated metastatic breast cancer in Spain
![Thumbnail](/xmlui/themes/Mirage2//images/thumbnails/thumn_cientif.png)
Identificadores![](/xmlui/themes/Mirage2//images/despl_identif.png)
Identificadores
Fecha de publicación
2013Título de revista
Expert review of pharmacoeconomics & outcomes research
Tipo de contenido
Artigo
![](/xmlui/themes/Mirage2//images/final_lines.png)